Page last updated: 2024-11-03

procarbazine and Lymphocytopenia

procarbazine has been researched along with Lymphocytopenia in 2 studies

Procarbazine: An antineoplastic agent used primarily in combination with mechlorethamine, vincristine, and prednisone (the MOPP protocol) in the treatment of Hodgkin's disease.
procarbazine : A benzamide obtained by formal condensation of the carboxy group of 4-[(2-methylhydrazino)methyl]benzoic acid with the amino group of isopropylamine. An antineoplastic chemotherapy drug used for treatment of Hodgkin's lymphoma. Metabolism yields azo-procarbazine and hydrogen peroxide, which results in the breaking of DNA strands.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Belkov, SA1
Andriukhin, VI1
Korsakov, VB1
Pugachev, VF1
Riazantsev, EA1
Floersheim, GL1
Brune, K1

Other Studies

2 other studies available for procarbazine and Lymphocytopenia

ArticleYear
[Plasmapheresis in the treatment of cytostatic disease in patients with lymphogranulomatosis].
    Gematologiia i transfuziologiia, 1991, Volume: 36, Issue:1

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide;

1991
The haematological response to the immunosuppressive methylhydrazine derivates procarbazine and Ro 4-6824.
    Acta haematologica, 1971, Volume: 46, Issue:2

    Topics: Animals; Antilymphocyte Serum; Antineoplastic Agents; Benzoates; Blood Platelets; Body Weight; Eryth

1971